Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,643 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

NCT00000870

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
View all 20 locations
View Trial Details
Completed

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 60 locations
View Trial Details
Completed

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

NCT00000923

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
View Trial Details
Completed

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

NCT00000903

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 50 locations
View Trial Details
Completed

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

NCT00000918

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Willow Clinic Menlo Park, California, United States
View all 39 locations
View Trial Details
Completed

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

NCT00001020

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • St Louis Univ School of Medicine St Louis, Missouri, United States
  • Univ of Pennsylvania at Philadelphia Philadelphia, Pennsylvania, United States
  • Children's Hospital & Medical Center / Seattle ACTU Seattle, Washington, United States
View Trial Details
Completed

Study of Anti-HIV Therapy Intensification

NCT00034086

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Case CRS Cleveland, Ohio, United States
View Trial Details
Completed

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

NCT00000674

Conditions
AIDS-Related Opportunistic Infections, Abscess, Acquired Immunodeficiency Syndrome, +31 more
Locations
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
View all 13 locations
View Trial Details

Related conditions